Corrigendum to ‘A systematic review and expert Delphi Consensus recommendation on the use of vaccines in patients receiving dupilumab: A position paper of the American College of Allergy, Asthma and Immunology’ [Annals of Allergy, Asthma & Immunology 133/3 (2024) 286-94]

IF 5.8 2区医学 Q1 ALLERGY

Annals of Allergy Asthma & Immunology Pub Date : 2025-02-01 DOI:10.1016/j.anai.2024.10.023

Jay A. Lieberman MD , Derek K. Chu MD, PhD , Tasnuva Ahmed MBBS, MPH, MSc , Timothy E. Dribin MD , Elissa M. Abrams MD , Aikaterini Anagnostou MD, MSc, PhD , Kimberly G. Blumenthal MD, MSc , Mark Boguniewicz MD , Nicole M. Chase MD , David B.K. Golden MDCM , Nicholas L. Hartog MD , Jennifer R. Heimall MD , Tina Ho MD, PhD , Monica G. Lawrence MD , David A. Khan MD , Timothy Dean Minniear MD, MSc , S. Shahzad Mustafa MD , John J. Oppenheimer MD , Elizabeth J. Phillips MD , Allison Ramsey MD , Matthew J. Greenhawt MD, MBA, MSc

引用次数: 0

查看原文本刊更多论文

对......的更正

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Annals of Allergy Asthma & Immunology 医学-过敏

CiteScore

6.50

自引率

6.80%

发文量

437

审稿时长

33 days

期刊介绍： Annals of Allergy, Asthma & Immunology is a scholarly medical journal published monthly by the American College of Allergy, Asthma & Immunology. The purpose of Annals is to serve as an objective evidence-based forum for the allergy/immunology specialist to keep up to date on current clinical science (both research and practice-based) in the fields of allergy, asthma, and immunology. The emphasis of the journal will be to provide clinical and research information that is readily applicable to both the clinician and the researcher. Each issue of the Annals shall also provide opportunities to participate in accredited continuing medical education activities to enhance overall clinical proficiency.